Skip to content

APOTHEEK FRANSEN

Active
Private limited companyfounded 1987active for 38 yearsVrijheid 160, 2320 Hoogstraten, BelgiumKBO/BCE: BE 0432.655.137
Summary

APOTHEEK FRANSEN has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €887,051 and a net result of €175,920. Equity has been growing by about 23% per year since 2018. Its solvency ranks better than 92% of 12,781 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-12-1987 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Pharmacies and pricing offices · annual accounts 2022
Establishment unit
2.031.676.084 2320 Hoogstraten, since 14-12-1987
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Fransen JoeriDirector · since 22-06-2021
Shareholders

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€386,029
▼ 3.3%
Turnover
≈ €1.4m
estimated
Profit
€175,920
▲ 12.1%
Equity
€887,051
▲ 5.2%
Total assets
€1.0m
▼ 7.1%
Employees on 31-12-2025
3
=
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 6.85, cash €183,028Founded in 1987Equity €887,051 (85.4% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 76% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 85.4% of total assets
Liquidity 69-13
short-term debt 14.4% · cash 17.6%
Profitability 90+17
return on assets 16.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,278 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.85 (7.39 in 2024), above the usual 1.5. Short-term debt is 14.4% and cash 17.6% of total assets. 14.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 75% on liquidity, 85% on profitability and 52% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 6.85, cash €183,028
NBB · annual accounts
lowers risk · Founded in 1987
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €887,051 (85.4% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
2 days early
2023
22 days early
2022
5 days early
2021
19 days early
2020
116 days early
2019
64 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 33 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 92% of companies in retail tradesector median 36.6% · 12,781 companies 85.4% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €175,920 8 years View

Recent changes

  1. · Gazette deed General meeting · Merger
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as APOTHEEK FRANSEN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €929,000 and €1.2m, founded between 1983 and 1991.

CompanyTotal assetsGross margin
APOTHEEK FRANSEN Hoogstraten€1.0m€0.4m
Apotheek THYS Houthalen-Helchteren€1.0m€0.4m
APOTHEEK SIMOENS R. Zottegem€1.1m€0.4m
Apotheek Pijpelheide Heist-op-den-Berg€1.2m€0.4m
APOTEEK VAN DER SYPT Beerse€0.9m€0.4m
RAMSELPHARMA Herselt€0.9m€0.5m
APOTHEEK DE FERM Antwerp€0.9m€0.5m
Full comparison

Key facts about APOTHEEK FRANSEN

What is the company number of APOTHEEK FRANSEN?
The company number of APOTHEEK FRANSEN is 0432.655.137. The VAT number is the same number with BE in front: BE 0432.655.137.
Where is APOTHEEK FRANSEN based?
The registered office is at Vrijheid 160, 2320 Hoogstraten.Company details
What does APOTHEEK FRANSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK FRANSEN?
APOTHEEK FRANSEN is a private limited company (BV).
When was APOTHEEK FRANSEN founded?
APOTHEEK FRANSEN was founded on 11-12-1987.
Is APOTHEEK FRANSEN still active?
Yes, APOTHEEK FRANSEN is an active enterprise in the KBO register.
How many employees does APOTHEEK FRANSEN have?
APOTHEEK FRANSEN had an average of 2.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK FRANSEN fall under?
In its 2022 annual accounts, APOTHEEK FRANSEN states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK FRANSEN?
The turnover in financial year 2025 is ≈ €1.4m. This figure is estimated from the gross margin of €386,029 and 47 comparable companies (NACE 477). It probably lies between €1.1m and €2.3m.
Is APOTHEEK FRANSEN profitable?
In financial year 2025, APOTHEEK FRANSEN made a profit of €175,920.
Where can I find the annual accounts of APOTHEEK FRANSEN?
APOTHEEK FRANSEN filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK FRANSEN due?
APOTHEEK FRANSEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.